Frontlight ResearchEarly access
CompletedPhase 1
A study to compare how different substances (caffeine, warfarin, omeprazole, metoprolol, and midazolam) are handled by the body of healthy people and people with liver cirrhosis
Key facts
- Who runs it
- Boehringer Ingelheim International GmbH
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 30 people enrolled
- Started
- 25 Apr 2023
- Ended
- 31 Dec 2024
- Type of study
- Interventional
- Record updated
- 26 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Where is this trial?
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 26 July 2024